Roadmap Meeting on Precision Psychiatry

Innovations in precision diagnostics and treatment strategies: from recognition to implementation

As part of its consensus Roadmap initiative for building a new diagnostic framework for mental disorders, ECNP will be organising a one-and-a-half-day meeting to discuss the development and implementation of novel targeted therapies in psychiatry on all fronts. Where previous meetings have focused predominantly on the research methodologies and the scientific rationale of precision psychiatry, this meeting aims to address the challenges and opportunities associated with making precision psychiatry a practical reality.

Recognising the broad implications for the treatment of brain disorders, all relevant stakeholders will be involved – from regulatory authorities, industry and the medical community, to health technology assessment professionals, patient advocacy groups, payer systems, and policymakers. Multistakeholder presentations and discussions are planned to review the current status of the uptake of innovations in psychiatry, assess the implementation challenges facing precision psychiatry approaches – from clinical development, trial design and regulatory pathways, to reimbursement and the complexities of the psychiatric care environment – and explore how our advancing understanding of mechanisms of action are opening up new research and treatment horizons.

In this way, we aim to further strengthen the value of innovation in psychiatry by bringing together international discussions across the global community and ensuring that scientific progress is shared at all levels of the mental health system.

The ECNP New Frontiers Meeting on 'Targeting neural circuits in psychiatry' was financially supported by the following companies, presented in alphabetical order: